Despite the encouraging quarterly performance and a 15.77% year-on-year profit growth, 20 Microns faces headwinds from a mildly bearish technical trend and underperformance against its sector peers, having declined 26.89% over the past year whilst the Minerals & Mining sector gained 20.16%. The company's market capitalisation stands at ₹633.00 crores.
The March 2026 quarter marked a strong finish to the financial year, with the company posting its highest-ever quarterly revenue and profit. The sequential revenue jump of 21.52% from ₹214.82 crores in Q3 FY26 was driven by improved demand conditions and better realisations. On an annual basis, FY2026 revenue reached ₹912.00 crores, representing a healthy 17.40% growth over FY2025's ₹777.00 crores.
| Quarter | Revenue (₹ Cr) | QoQ Growth | Net Profit (₹ Cr) | QoQ Growth | PAT Margin |
|---|---|---|---|---|---|
| Mar'26 | 261.06 | +21.52% | 17.62 | +17.78% | 6.74% |
| Dec'25 | 214.82 | -6.92% | 14.96 | -14.02% | 6.92% |
| Sep'25 | 230.78 | -6.63% | 17.40 | +3.20% | 7.52% |
| Jun'25 | 247.16 | +8.68% | 16.86 | +10.78% | 6.82% |
| Mar'25 | 227.41 | +5.94% | 15.22 | +18.08% | 6.69% |
| Dec'24 | 214.65 | -10.63% | 12.89 | -21.45% | 6.02% |
| Sep'24 | 240.18 | — | 16.41 | — | 6.85% |
Financial Performance: Solid Growth Marred by Margin Pressures
20 Microns delivered a commendable topline performance in Q4 FY26, with net sales reaching a record ₹261.06 crores, marking a 14.80% year-on-year increase from ₹227.41 crores in Q4 FY25. The quarter-on-quarter jump of 21.52% from ₹214.82 crores in Q3 FY26 reflects strong demand momentum heading into the year-end. For the full financial year FY2026, revenue stood at ₹912.00 crores, up 17.40% from ₹777.00 crores in FY2025, demonstrating consistent growth trajectory.
However, profitability metrics present a more nuanced picture. Whilst consolidated net profit for Q4 FY26 climbed to ₹17.62 crores—a 17.78% sequential improvement and 15.77% year-on-year gain—operating margins witnessed compression. The operating profit margin (excluding other income) stood at 12.17% in Q4 FY26, declining 73 basis points quarter-on-quarter from 12.90% in Q3 FY26, though remaining marginally ahead of the year-ago quarter's 12.75%.
The company's PAT margin for Q4 FY26 came in at 6.74%, down from 6.92% in the previous quarter but higher than the 6.69% recorded in Q4 FY25. For the full year FY2026, PAT margin stood at 6.80%, marginally below FY2025's 7.20%, reflecting the impact of elevated operational costs. Employee costs rose to ₹22.11 crores in Q4 FY26 from ₹20.85 crores in Q3 FY26, whilst depreciation increased to ₹5.18 crores from ₹4.90 crores.
On a positive note, the company's interest burden continued to decline, falling to ₹3.92 crores in Q4 FY26 from ₹4.08 crores in Q3 FY26 and ₹4.77 crores in Q4 FY25. This improvement in interest costs, combined with higher operating profit, pushed the interest coverage ratio to a record 8.10 times in Q4 FY26, significantly strengthening the company's debt servicing capability.
Operational Strength: Robust Capital Efficiency Despite Quality Concerns
20 Microns demonstrates solid operational efficiency, with Return on Capital Employed (ROCE) standing at 17.63% as of March 2026. This reflects the company's ability to generate healthy returns from its capital base, significantly above the cost of capital. The five-year average ROCE of 17.88% underscores consistent capital productivity, positioning the company favourably within the capital-intensive minerals and mining sector.
However, Return on Equity (ROE) presents a more modest picture at 13.91% for the latest period, with a five-year average of 15.00%. Whilst this is respectable, it falls short of the 20%+ threshold typically associated with high-quality compounders. The relatively lower ROE compared to ROCE suggests moderate financial leverage, with the company maintaining a conservative balance sheet approach.
The company's balance sheet reveals prudent financial management. As of March 2026, shareholder funds stood at ₹429.36 crores, up from ₹352.95 crores in March 2025, reflecting retained earnings growth. Long-term debt remained manageable at ₹22.21 crores, though it increased from ₹12.41 crores in the previous year, indicating some incremental borrowing to fund capital expenditure. Fixed assets rose to ₹271.35 crores from ₹206.77 crores, suggesting ongoing capacity expansion initiatives.
⚠️ Quality Downgrade Alert
20 Microns' quality rating was downgraded from "Good" to "Average" in February 2026. Key concerns include weak interest coverage (4.67x average) and modest ROE of 15.00%. The company's five-year sales CAGR of 14.34% is considered below par for sustained wealth creation, though EBIT growth of 20.46% shows improving profitability. Institutional holdings remain negligible at 0.52%, suggesting limited participation from sophisticated investors.
The company's debt metrics paint a relatively healthy picture. The debt-to-EBITDA ratio stands at a comfortable 1.37 times, indicating strong ability to service debt obligations. Net debt to equity is low at 0.23, reflecting minimal leverage and financial flexibility. The average EBIT to interest coverage of 4.67 times, whilst adequate, remains on the weaker side and warrants monitoring, particularly if interest rates remain elevated.
Cash Flow Dynamics: Working Capital Strain Impacts Liquidity
20 Microns' cash flow statement for FY2026 reveals significant working capital pressures that constrained operational cash generation. Despite reporting a profit before tax of ₹82.00 crores for FY2026, the company witnessed a substantial working capital outflow of ₹65.00 crores, nearly double the ₹33.00 crores outflow in FY2025. This resulted in cash flow from operations declining to ₹31.00 crores in FY2026 from ₹54.00 crores in FY2025.
The elevated working capital requirement likely stems from increased inventory levels and trade receivables to support the 17.40% revenue growth. Current assets expanded to ₹375.16 crores in March 2026 from ₹331.91 crores in March 2025, whilst current liabilities rose to ₹219.31 crores from ₹189.54 crores. Trade payables increased to ₹68.38 crores from ₹62.03 crores, indicating some supplier credit support.
Capital expenditure remained elevated at ₹63.00 crores in FY2026, significantly higher than ₹23.00 crores in FY2025, reflecting the company's ongoing capacity expansion plans. This, combined with weak operational cash flows, resulted in a net cash outflow of ₹17.00 crores for the year. Closing cash balance declined to ₹31.00 crores from ₹48.00 crores, though the company raised ₹14.00 crores through financing activities to partially bridge the gap.
Peer Comparison: Attractive Valuation But Lagging Profitability
20 Microns trades at a significant valuation discount compared to its minerals and mining sector peers, offering investors an attractive entry point from a multiple perspective. At a price-to-earnings ratio of 9.61x, the stock trades well below the sector median and at a substantial discount to peers like Gravita India (32.02x) and Ashapura Minechem (16.94x). The company's price-to-book value of 1.37x also appears reasonable, particularly when compared to Gravita India's 4.95x and Ashapura Minechem's 4.53x.
| Company | P/E (TTM) | P/BV | ROE (%) | Debt/Equity | Div Yield (%) |
|---|---|---|---|---|---|
| 20 Microns | 9.61 | 1.37 | 15.00 | 0.23 | 0.71 |
| Gravita India | 32.02 | 4.95 | 25.86 | 0.06 | — |
| Ashapura Minechem | 16.94 | 4.53 | 21.32 | 0.63 | 0.15 |
| MOIL | 22.97 | 2.27 | 12.66 | -0.37 | 2.29 |
| Bharat Coking | 942.06 | 2.74 | 0.00 | 0.00 | — |
However, the valuation discount is partially justified by 20 Microns' inferior profitability metrics. The company's ROE of 15.00% trails behind Gravita India's impressive 25.86% and Ashapura Minechem's 21.32%. Even MOIL, despite its lower valuation multiples, demonstrates comparable ROE at 12.66%. This profitability gap explains why the market accords a premium to peers with superior returns on equity.
On the leverage front, 20 Microns maintains a conservative balance sheet with a debt-to-equity ratio of 0.23, lower than Ashapura Minechem's 0.63 but higher than Gravita India's minimal 0.06. The company's dividend yield of 0.71% is modest, reflecting a conservative payout policy with a 7.07% dividend payout ratio, as management appears to prioritise reinvestment for growth over shareholder distributions.
Valuation Analysis: Compelling Entry Point Despite Near-Term Headwinds
At the current market price of ₹177.65, 20 Microns presents a compelling valuation case, particularly for patient investors with a medium to long-term horizon. The stock's P/E ratio of 9.61x represents a significant discount to the industry average of 11x, suggesting the market is pricing in concerns about near-term growth sustainability and operational challenges. The EV/EBITDA multiple of 6.05x appears attractive for a company demonstrating consistent revenue growth and improving profitability trends.
The company's Enterprise Value to Capital Employed ratio of 1.30x, when juxtaposed with its ROCE of 17.63%, indicates value creation potential. The stock generates returns on capital that are approximately 13.5 times its EV/CE multiple, suggesting the market may be undervaluing the company's ability to generate returns from its asset base. The EV/Sales ratio of 0.79x also appears reasonable for a minerals processing company with established market presence.
However, the valuation grade has witnessed volatility, oscillating between "Very Attractive" and "Attractive" multiple times between April and May 2025, before settling at "Very Attractive" currently. This suggests the stock is range-bound and sensitive to quarterly performance variations. The PEG ratio of 1.85 indicates the stock is trading at a premium to its growth rate, which may limit near-term upside unless growth accelerates beyond current trajectories.
The stock's current price of ₹177.65 represents a 37.47% decline from its 52-week high of ₹284.10, offering a substantial margin of safety for new investors. Conversely, it trades 36.13% above its 52-week low of ₹130.50, suggesting some recovery from recent lows. Based on fundamental analysis and peer comparison, a fair value estimate of ₹210-220 appears reasonable, implying 18-24% upside potential from current levels over the next 12-18 months.
Shareholding Pattern: Stable Promoter Base, Minimal Institutional Interest
The shareholding pattern of 20 Microns reveals a stable ownership structure with consistent promoter commitment, though institutional participation remains conspicuously absent. Promoter holding has remained steady at 45.04% across the last five quarters through March 2026, demonstrating unwavering confidence from the founding family. The promoter group is led by Ionix Advanced Materials Private Limited with a 24.56% stake, followed by family members Ilaben Chandresh Parikh (9.02%), Rajesh Chandresh Parikh (5.73%), and Atil Chandresh Parikh (5.73%).
| Quarter | Promoter | FII | MF | Insurance | Other DII | Public |
|---|---|---|---|---|---|---|
| Mar'26 | 45.04% | 0.41% | 0.00% | 0.00% | 0.11% | 54.44% |
| Dec'25 | 45.04% | 0.26% | 0.00% | 0.00% | 0.07% | 54.63% |
| Sep'25 | 45.04% | 0.26% | 0.00% | 0.00% | 0.18% | 54.52% |
| Jun'25 | 45.04% | 0.88% | 0.00% | 0.00% | 0.15% | 53.93% |
| Mar'25 | 45.04% | 0.84% | 0.00% | 0.00% | 0.15% | 53.96% |
Foreign Institutional Investor (FII) holding witnessed marginal improvement to 0.41% in March 2026 from 0.26% in December 2025, though it remains significantly below the 0.88% recorded in June 2025. The sequential increase of 15 basis points suggests tentative interest from overseas investors, with six FIIs currently holding stakes in the company. However, the overall FII participation remains negligible, reflecting limited global investor attention on this micro-cap stock.
The complete absence of mutual fund holdings (0.00% across all quarters) and insurance company participation raises concerns about institutional validation of the company's investment thesis. Other Domestic Institutional Investors (DIIs) hold a minimal 0.11% stake as of March 2026, up marginally from 0.07% in the previous quarter. The non-institutional and retail investor base comprises 54.44% of shareholding, indicating this remains predominantly a retail-driven stock lacking institutional sponsorship.
On a positive note, promoter pledging stands at zero, eliminating concerns about financial stress or liquidity constraints at the promoter level. The stable promoter holding over multiple quarters, combined with no pledging, reflects strong alignment with minority shareholders and confidence in the company's long-term prospects. However, the absence of meaningful institutional participation suggests the stock may lack the liquidity and research coverage typically associated with institutional favourites.
Stock Performance: Significant Underperformance Amid Technical Weakness
20 Microns has delivered disappointing returns across most timeframes, significantly underperforming both the broader market and its sectoral peers. Over the past year, the stock has declined 26.89%, whilst the Sensex fell 6.84%, resulting in a negative alpha of 20.05 percentage points. More concerning is the stock's 47.05 percentage point underperformance versus the Minerals & Mining sector, which gained 20.16% during the same period.
| Period | Stock Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Week | +2.16% | +0.24% | +1.92% |
| 1 Month | -0.14% | -3.95% | +3.81% |
| 3 Months | -0.59% | -8.93% | +8.34% |
| 6 Months | -6.92% | -11.52% | +4.60% |
| YTD | -16.64% | -11.51% | -5.13% |
| 1 Year | -26.89% | -6.84% | -20.05% |
| 3 Years | +111.49% | +21.71% | +89.78% |
| 5 Years | +183.11% | +49.22% | +133.89% |
The near-term picture shows marginal improvement, with the stock gaining 2.16% over the past week and outperforming the Sensex by 1.92 percentage points. Over the past month and quarter, 20 Microns has demonstrated relative strength, declining just 0.14% and 0.59% respectively, whilst the Sensex fell 3.95% and 8.93%. This recent resilience suggests some stabilisation after the prolonged downturn.
However, the longer-term performance paints a more favourable picture. Over three years, the stock has delivered impressive returns of 111.49%, significantly outperforming the Sensex's 21.71% gain with a positive alpha of 89.78 percentage points. The five-year return of 183.11% (versus Sensex's 49.22%) and ten-year return of 463.07% (versus Sensex's 198.06%) demonstrate substantial wealth creation for patient, long-term investors who held through market cycles.
The stock's risk profile remains elevated, with one-year volatility at 43.65%—more than three times the Sensex's 12.94% volatility. The beta of 1.25 indicates the stock is 25% more volatile than the broader market, classifying it as a high-beta stock. The negative risk-adjusted return of -0.62 over the past year reflects poor performance relative to the volatility undertaken, placing the stock in the "High Risk Low Return" category—an unfavourable combination for risk-conscious investors.
Technical Analysis: Mildly Bearish Trend Amid Mixed Signals
20 Microns currently trades in a "Mildly Bearish" technical trend, which commenced on May 20, 2026, at ₹180.60, transitioning from the previous "Bearish" trend. The stock price of ₹177.65 as of May 22, 2026, remains below multiple key moving averages, indicating persistent technical weakness despite the recent trend upgrade to "mildly bearish" from outright "bearish."
The moving average structure reveals concerning signals. The stock trades below its 5-day moving average of ₹173.73, 20-day moving average of ₹177.35, 50-day moving average of ₹166.68, 100-day moving average of ₹176.14, and significantly below its 200-day moving average of ₹195.05. The 200-day moving average, in particular, represents a major resistance level approximately 9.8% above current prices, suggesting a meaningful technical overhang.
Technical indicators present a mixed picture across timeframes. On the weekly charts, MACD shows "Mildly Bullish" signals, whilst Bollinger Bands indicate "Bullish" positioning, suggesting potential for near-term upside. The KST indicator also flashes "Mildly Bullish," whilst Dow Theory remains "Mildly Bearish." However, monthly indicators paint a more cautious picture, with MACD turning "Mildly Bearish," Bollinger Bands "Mildly Bearish," and KST firmly "Bearish."
The RSI indicator shows "No Signal" on both weekly and monthly timeframes, suggesting the stock is neither overbought nor oversold at current levels. On-Balance Volume (OBV) displays "No Trend" on weekly charts but "Mildly Bullish" on monthly charts, indicating gradual accumulation over longer timeframes despite near-term volatility. Delivery volumes have increased 39.2% over the trailing one-month period compared to the previous month, with the latest session showing 39.61% delivery—significantly above the five-day average of 28.14%—suggesting genuine investor interest rather than speculative trading.
Investment Thesis: Value Play With Execution Risks
The investment case for 20 Microns rests on four key pillars: attractive valuation, improving financial trends, average quality fundamentals, and challenging technical setup. The company's proprietary Mojo Score stands at 51 out of 100, placing it in "HOLD" territory after recently upgrading from "SELL" category. This score reflects the balanced risk-reward profile, with compelling valuation offset by operational and technical concerns.
The valuation pillar offers the strongest support for the investment thesis. At 9.61x trailing earnings and 1.37x book value, 20 Microns trades at a significant discount to both historical averages and peer group multiples. The EV/EBITDA of 6.05x and EV/Capital Employed of 1.30x appear attractive for a company generating 17.63% ROCE, suggesting the market is undervaluing the company's return-generating capability. This valuation cushion provides downside protection and potential for multiple re-rating if operational performance continues to improve.
The financial trend has turned decisively positive following the strong Q4 FY26 performance. Record quarterly revenue of ₹261.06 crores and net profit of ₹17.62 crores, combined with the highest-ever interest coverage ratio of 8.10 times, demonstrate improving operational momentum. The company's ability to grow revenue by 17.40% in FY2026 whilst maintaining margins around 12-13% reflects resilient business fundamentals. However, the working capital intensity and modest ROE of 15.00% prevent this from being classified as a high-quality compounder.
✅ Key Strengths
- Record quarterly revenue of ₹261.06 crores in Q4 FY26, highest in company history
- Interest coverage ratio at all-time high of 8.10x, demonstrating strong debt servicing ability
- Attractive valuation at 9.61x P/E and 6.05x EV/EBITDA, trading below industry average
- Conservative balance sheet with low debt-to-EBITDA of 1.37x and net debt-to-equity of 0.23
- Zero promoter pledging with stable 45.04% promoter holding over past five quarters
- Healthy ROCE of 17.63% indicating efficient capital deployment
- Consistent revenue growth with 17.40% increase in FY2026 and 14.34% five-year CAGR
⚠️ Key Concerns
- Stock underperformed sector by 47.05 percentage points over past year (-26.89% vs +20.16%)
- Mildly bearish technical trend with price 37.47% below 52-week high of ₹284.10
- Quality downgrade from "Good" to "Average" in February 2026 due to weakening metrics
- Modest ROE of 15.00% below the 20%+ threshold for high-quality compounders
- Significant working capital outflow of ₹65.00 crores in FY2026 strained cash flows
- Zero mutual fund and insurance company holdings indicate lack of institutional validation
- Operating margin compression to 12.17% in Q4 FY26 from 12.90% in Q3 FY26
Outlook: Monitoring Points for Trend Reversal
The outlook for 20 Microns over the next 12-18 months hinges on the company's ability to sustain revenue momentum whilst improving profitability metrics and attracting institutional investor interest. The management's capacity expansion initiatives, reflected in elevated capital expenditure of ₹63.00 crores in FY2026, should begin contributing to topline growth in coming quarters. However, investors must monitor whether these investments translate into margin expansion or continue to pressure returns.
Positive Catalysts
- Sustained quarterly revenue growth above 15% with margin stability around 12-13%
- Working capital cycle improvement with operating cash flows exceeding ₹60 crores annually
- Entry of mutual funds or insurance companies signalling institutional validation
- Technical trend reversal to "Bullish" with stock reclaiming 200-day moving average
- ROE improvement beyond 18% demonstrating enhanced capital efficiency
Red Flags to Watch
- Quarterly revenue growth falling below 10% indicating demand slowdown
- Operating margins declining below 11% due to input cost pressures
- Working capital outflows exceeding ₹70 crores annually straining liquidity
- Debt-to-EBITDA ratio rising above 2.0x indicating leveraging concerns
- Stock breaking below ₹130.50 (52-week low) on high volumes
The minerals and mining sector's outlook remains constructive, supported by infrastructure development and industrial demand. However, 20 Microns' ability to capitalise on sectoral tailwinds depends on operational execution and competitive positioning. The company's specialisation in functional fillers and extenders provides some differentiation, but margin pressures from raw material costs and competition require vigilant cost management.
For existing shareholders, the positive financial trend and attractive valuation provide justification to maintain positions, particularly for those with long-term investment horizons. The stock's three-year return of 111.49% and five-year return of 183.11% demonstrate the potential for wealth creation through market cycles. However, fresh investors should await technical trend reversal and evidence of sustained margin improvement before initiating positions, given the current mildly bearish technical setup and 26.89% one-year decline.
The Verdict: Hold With Cautious Optimism
Score: 51/100
For Fresh Investors: Avoid initiating positions at current levels. Wait for technical trend reversal to "Bullish" and stock reclaiming the 200-day moving average at ₹195.05 before considering entry. The attractive valuation provides downside cushion, but near-term momentum remains weak.
For Existing Holders: Continue holding positions. The improving financial trend, record quarterly performance, and attractive valuation justify maintaining exposure. Consider averaging down if the stock tests the ₹160-165 support zone with improving technical indicators. Set mental stop-loss at ₹130 (52-week low).
Fair Value Estimate: ₹210-220 (18-24% upside potential over 12-18 months based on 12x P/E on FY2027 estimated earnings of ₹18 per share)
Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results. The stock market involves risks, and investors may lose some or all of their invested capital.
